PER 1.41% 7.0¢ percheron therapeutics limited

Ann: ANP Updates on US Regulatory Plans for ATL1102 in DMD, page-115

  1. 1,703 Posts.
    lightbulb Created with Sketch. 605
    I’d think I’d be a bit disappointed if management “caved” to nervous nellies. If you believe the investment thesis then turn off the computer & await the science to drive the SP. That said - of some concern is the fact that management seemingly “didn’t get it right the first time” . In a similar vein the communication was pretty ham fisted which raises its own questions too. Let’s hope they get their A team into the game when it comes to deal making & assessing the financing alternatives.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
-0.001(1.41%)
Mkt cap ! $63.10M
Open High Low Value Volume
7.1¢ 7.1¢ 6.9¢ $34.01K 486.5K

Buyers (Bids)

No. Vol. Price($)
2 132919 6.9¢
 

Sellers (Offers)

Price($) Vol. No.
7.3¢ 78000 1
View Market Depth
Last trade - 16.10pm 02/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.